TOP STORIES

• BUSINESS Lilly’s Omvoh Launch Set for June 21; BioMarin’s Palynziq Now Available
  May 25, 2023

• BUSINESS Novartis Japan Rolling Out New Operational Model Tailored to Local Needs: President
  May 24, 2023

• COMMENTARY Will Wegovy Lead the Way in Changing Picture of Obesity Treatment in Japan?
  May 23, 2023

• REGULATORY LDP Pharma Study Group Proposes Removing Cap for Social Security Costs
  May 23, 2023

• REGULATORY Ophthalmic Mitomycin, OD Tablets for Takecab and Tarlige to Get Listing on May 24
  May 23, 2023

• REGULATORY MHLW Cancels Expert Panel Meeting on May 23, Report Delayed
  May 23, 2023

• BUSINESS Sawai and Towa Profits Tank 50% on Flat Sales in Japan: FY2022 Earnings
  May 22, 2023

• BUSINESS Astellas CEO Confident about Veozah Uptake, 500 Billion Yen Sales Potential
  May 22, 2023

• ORGANIZATION Industry, Academia Groups Applaud Govt’s New Biosimilar Goal, but Fret Pricing, Biosame Issues
  May 19, 2023

• BUSINESS Qol to Further Expand Espha's AG Biz, Eyes Biosame Territory: Exec
  May 19, 2023

• BUSINESS Lecanemab’s Social Value in Japan Simulated at 4.7 Million Yen per Patient/Year: Eisai
  May 18, 2023

• REGULATORY Market Expansion Re-Pricing to Hit Tarlige, Entresto, Verzenio; Spillover to 2 Other Meds
  May 18, 2023

• REGULATORY Create Command Tower to Integrate Innovation Support and Drug Pricing Policy: LDP Project Chief
  May 17, 2023

• REGULATORY Chuikyo OKs Listing of Omvoh, Entyvio SC, Besremi, and More; Biggest Sales Outlook for Lilly Drug
  May 17, 2023

• REGULATORY Novo’s Obesity Drug Wegovy Skips May Listing, Sobi’s Empaveli Too
  May 17, 2023

• BUSINESS Daiichi Sankyo Set to Sharpen Focus on Innovation with Generic Divestment
  May 17, 2023

• BUSINESS Daiichi Sankyo to Divest Espha Generic Unit for 25 Billion Yen
  May 16, 2023

• BUSINESS 400 Staffers Pitching Leqembi in US, Tapping Digital Tools: Eisai CEO
  May 16, 2023

• BUSINESS FDA Approves Astellas’ Blockbuster Hopeful for Hot Flash Treatment
  May 16, 2023

• REGULATORY G7 Health Chiefs Vow to Spur Antibiotic and Dementia Drug Development, Access to Vaccines
  May 15, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 54
• 55
• 56
• 57
• 58
• 59
• 60
• 61
• 62
• …
• Next ›
• 最終 »